Dolphimed A/S: Financial statements 2023
CVR: 42539023
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Dolphimed A/S (CVR 42539023) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -1,931,937 and a net result of DKK -6,435,051. Equity in the 2023 report amounted to DKK -26,165,712.
- Gross Profit
- DKK -1,931,937
- Profit/Loss
- DKK -6,435,051
- Equity
- DKK -26,165,712
- Total Assets
- DKK 16,994,333
- Employees
- 0
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Dolphimed A/S has published its interim report for the period July 1, 2021 – December 31, 2022.
As of June 28, 2023, Spiros Kotopoulis has joined the board of directors of Dolphimed A/S.
As of June 28, 2023, Henrik Lassen has left the board of directors of Dolphimed A/S.
As of May 12, 2023, Ole Johan Gillebo has joined the board of directors of Dolphimed A/S.
As of May 12, 2023, Per Christian Methi has joined the board of directors of Dolphimed A/S.
As of May 12, 2023, Ole Johan Gillebo is registered as adm. dir. of Dolphimed A/S.
As of May 11, 2023, Ole Johan Gillebo has left the board of directors of Dolphimed A/S.
As of May 11, 2023, Per Christian Methi has left the board of directors of Dolphimed A/S.
As of March 31, 2023, Henrik Lassen has stepped down as director of Dolphimed A/S.
About Dolphimed A/S
Dolphimed A/S is a Danish company of the type Aktieselskab based in København K, founded in 2021. The company is in liquidation. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named A/S KBUS 18 nr. 198. The management consists of Preben Jakobsen. The company is owned by Asset Segregated SPV #114 IC, Escala Capital AS and KOMM-IN AS. The company has 1 employee (2022). In 2024, the company reported a gross profit of DKK -163,373 and a net result of DKK -5,168,947 compared with DKK -6,435,051 the year before. Equity in the 2024 report amounted to DKK -31,334,659.